Faculty of 1000 evaluation for Rationale and design of the Investigation of the Management of Pericarditis (IMPI) trial: A 2 × 2 factorial randomized double-blind multicenter trial of adjunctive prednisolone and Mycobacterium w immunotherapy in tuberculous pericarditis.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.717976620.793472073 ◽

2013 ◽

Author(s):

John Paraskos

Keyword(s):

Multicenter Trial ◽

Double Blind ◽

Tuberculous Pericarditis ◽

Mycobacterium W

Download Full-text

Faculty Opinions recommendation of Rationale and design of the Investigation of the Management of Pericarditis (IMPI) trial: a 2 × 2 factorial randomized double-blind multicenter trial of adjunctive prednisolone and Mycobacterium w immunotherapy in tuberculous pericarditis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717976620.793472543 ◽

2013 ◽

Author(s):

Direk Limmathurotsakul ◽

Cherry Lim

Keyword(s):

Multicenter Trial ◽

Double Blind ◽

Tuberculous Pericarditis ◽

Mycobacterium W

Download Full-text

Faculty Opinions recommendation of Rationale and design of the Investigation of the Management of Pericarditis (IMPI) trial: a 2 × 2 factorial randomized double-blind multicenter trial of adjunctive prednisolone and Mycobacterium w immunotherapy in tuberculous pericarditis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717976620.793472114 ◽

2013 ◽

Author(s):

David Murdoch ◽

Gary McAuliffe

Keyword(s):

Multicenter Trial ◽

Double Blind ◽

Tuberculous Pericarditis ◽

Mycobacterium W

Download Full-text

Rationale and design of the Investigation of the Management of Pericarditis (IMPI) trial: A 2 × 2 factorial randomized double-blind multicenter trial of adjunctive prednisolone and Mycobacterium w immunotherapy in tuberculous pericarditis

American Heart Journal ◽

10.1016/j.ahj.2012.08.006 ◽

2013 ◽

Vol 165 (2) ◽

pp. 109-115.e3 ◽

Author(s):

Bongani M. Mayosi ◽

Mpiko Ntsekhe ◽

Jackie Bosch ◽

Janice Pogue ◽

Freedom Gumedze ◽

...

Keyword(s):

Multicenter Trial ◽

Double Blind ◽

Tuberculous Pericarditis ◽

Mycobacterium W

Download Full-text

Oral budenosid is highly effective in the treatment of collagenous colitis: A randomized, double-blind, placebo-controlled, multicenter trial

Gastroenterology ◽

10.1016/s0016-5085(01)80196-7 ◽

2001 ◽

Vol 120 (5) ◽

pp. A40-A40 ◽

Author(s):

S MIEHLKE ◽

P HEYMER ◽

T OCHSENKUEHN ◽

E BAESTLEIN ◽

G YARIAN ◽

...

Keyword(s):

Collagenous Colitis ◽

Multicenter Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Highly Effective

Download Full-text

Efficacy and safety of STW 5 II in patients with functional dyspepsia: results from a double-blind, randomized, multicenter trial

10.1055/s-0040-1716211 ◽

2020 ◽

Author(s):

B Vinson ◽

G Holtmann

Keyword(s):

Functional Dyspepsia ◽

Multicenter Trial ◽

Efficacy And Safety ◽

Download Full-text

Faculty Opinions recommendation of Low-level light therapy for androgenetic alopecia: a 24-week, randomized, double-blind, sham device-controlled multicenter trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717996993.793502316 ◽

2014 ◽

Author(s):

Juan Ferrando ◽

José M Mir-Bonafé

Keyword(s):

Light Therapy ◽

Multicenter Trial ◽

Androgenetic Alopecia ◽

Double Blind ◽

Low Level Light Therapy ◽

Download Full-text

Efficacy of activated recombinant factor VII (rFVIIa; novoseven) in cirrhotic patients with upper gastrointestinal bleeding: A randomized placebo-controlled double-blind multicenter trial

Gastroenterology ◽

10.1016/s0016-5085(03)83525-4 ◽

2003 ◽

Vol 124 (4) ◽

pp. A697 ◽

Author(s):

Dominique Thabut ◽

Roberto De Franchis ◽

Flemming Bendtsen ◽

Gennaro D'Amico ◽

Agustin Albillos ◽

...

Keyword(s):

Gastrointestinal Bleeding ◽

Upper Gastrointestinal Bleeding ◽

Multicenter Trial ◽

Double Blind ◽

Cirrhotic Patients ◽

Upper Gastrointestinal

Download Full-text

OP7 EFFICACY, SAFETY, AND TOLERABILITY OF IPRAGLIFLOZIN IN ASIAN TYPE 2 DIABETIC PATIENTS WITH INADEQUATE GLYCEMIC CONTROL WITH METFORMIN. RESULTS OF A PHASE 3 RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER TRIAL

Diabetes Research and Clinical Practice ◽

10.1016/s0168-8227(14)70213-x ◽

2014 ◽

Vol 106 ◽

pp. S4 ◽

Author(s):

L.-M. Chuang ◽

K.W. Min ◽

C.-H. Lu ◽

S. Kokubo ◽

S. Yoshida ◽

...

Keyword(s):

Glycemic Control ◽

Multicenter Trial ◽

Diabetic Patients ◽

Type 2 Diabetic Patients ◽

Phase 3 ◽

Double Blind ◽

Type 2 Diabetic ◽

Inadequate Glycemic Control

Download Full-text

DGAVP (Org 5667) in early Alzheimer??s disease patients: an international double-blind, placebo-controlled multicenter trial

Alzheimer Disease & Associated Disorders ◽

10.1097/00002093-199100530-00014 ◽

1991 ◽

Vol 5 (3) ◽

pp. 205

Author(s):

ECh Wolters ◽

P Riekkinen ◽

A Lowenthal ◽

JJ Van der Plaats ◽

JMT Zwart ◽

...

Keyword(s):

Multicenter Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial

The Journal of Headache and Pain ◽

10.1186/s10194-015-0516-6 ◽

2015 ◽

Vol 16 (1) ◽

Author(s):

Charly Gaul ◽

◽

Hans-Christoph Diener ◽

Ulrich Danesch

Keyword(s):

Multicenter Trial ◽

Download Full-text